VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SLDESlide Insurance Holdings, Inc. Common Stock
$19.09$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSLDEQuarterly Financials

Slide Insurance Holdings, Inc. Common Stock (SLDE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Slide Insurance Holdings, Inc. Common Stock (SLDE) quarterly income statement — complete revenue, gross profit & net income history

SLDE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue389.28M347.01M265.69M261.61M281.59M238.45M200.1M209.13M199.13M153.82M
Revenue Growth %38.24%45.52%32.78%25.09%41.41%55.02%----
Medical Costs & Claims111.07M-69.97M69.63M123.47M112.33M88.18M133.68M107.3M96.1M78.39M
Medical Cost Ratio %28.53%-20.16%26.21%47.19%39.89%36.98%66.81%51.31%48.26%50.96%
Gross Profit278.21M416.98M196.06M138.14M169.26M150.28M66.42M101.83M103.03M75.43M
Gross Margin %71.47%120.16%73.79%52.81%60.11%63.02%33.19%48.69%51.74%49.04%
Gross Profit Growth %64.37%177.48%195.17%35.66%64.29%99.23%----
Operating Expenses92.53M194.96M49.05M41.84M45.35M49.48M42.05M30.38M29.67M30.81M
OpEx / Revenue %23.77%56.18%18.46%16%16.11%20.75%21.02%14.53%14.9%20.03%
Depreciation & Amortization0-12.23M3.13M3.01M3.04M2.83M2.85M2.32M2.31M2.65M
Combined Ratio %52.3%36.02%44.67%63.19%56%57.73%87.82%65.84%63.16%70.99%
Operating Income185.68M222.02M147.01M96.3M123.91M100.8M24.37M71.45M73.36M44.62M
Operating Margin %47.7%63.98%55.33%36.81%44%42.27%12.18%34.16%36.84%29.01%
Operating Income Growth %49.85%120.26%503.31%34.78%68.91%125.9%----
EBITDA185.68M209.79M150.15M99.31M126.95M103.63M27.22M73.77M75.66M47.28M
EBITDA Margin %47.7%60.46%56.51%37.96%45.08%43.46%13.6%35.27%38%30.73%
Interest Expense852K892K909K895K934K789K1.38M1.31M280K1.13M
Non-Operating Income-852K-893K-909K-895K-934K-789K-1.38M-1.31M-280K-1.03M
Pretax Income185.68M222.02M147.01M96.3M123.91M100.8M24.37M71.45M73.36M44.52M
Pretax Margin %47.7%63.98%55.33%36.81%44%42.27%12.18%34.16%36.84%28.94%
Income Tax46.15M51.63M36.02M26.23M31.4M25.71M6.79M17.71M18.65M11.44M
Effective Tax Rate %24.85%23.26%24.5%27.23%25.34%25.5%27.87%24.78%25.42%25.7%
Net Income139.53M170.39M111M70.07M92.5M75.09M17.58M53.74M54.71M33.08M
Net Margin %35.84%49.1%41.78%26.79%32.85%31.49%8.78%25.7%27.48%21.51%
Net Income Growth %50.84%126.9%531.49%30.39%69.07%127.01%----
EPS (Diluted)1.021.230.790.560.740.600.140.430.440.26
EPS Growth %37.84%105%464.29%30.23%68.18%130.77%----
EPS (Basic)1.131.380.890.560.740.600.140.430.440.26
Diluted Shares Outstanding136.59M138.25M140.11M125.98M124.93M124.93M124.93M124.93M124.93M124.93M